Method For Production Of Mast Cells From Stem Cells


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

Christine Daigh , Deepika Rajesh

ABSTRACT

Provided are methods for generating mast cells from pluripotent stem cells in vitro. Methods are disclosed for the differentiation of pluripotent cells, such as iPS cells and/or human embryonic stem cells, into mast cells. The resulting mast cells may be used for various purposes including screening cells for drug development and research. Growth factors which may be included in culture media according to the present invention include stem cell factor (SCF), FLT-3 ligand, thrombopoietin (TPO), interleukin-3 (IL-3), and/or interleukin-6 (IL-6). More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2581", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2995", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Christine Daigh", 
        "type": "Person"
      }, 
      {
        "name": "Deepika Rajesh", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.theriogenology.2010.04.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007552463"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/stemcells.2007-0348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011839783"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.theriogenology.2009.11.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013693696"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.theriogenology.2009.09.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027967774"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt1177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030407065", 
          "https://doi.org/10.1038/nbt1177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(95)00034-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033328601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.exphem.2008.04.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035969756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jez.535", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049055947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/news.2008.1336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056454267"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

Provided are methods for generating mast cells from pluripotent stem cells in vitro. Methods are disclosed for the differentiation of pluripotent cells, such as iPS cells and/or human embryonic stem cells, into mast cells. The resulting mast cells may be used for various purposes including screening cells for drug development and research. Growth factors which may be included in culture media according to the present invention include stem cell factor (SCF), FLT-3 ligand, thrombopoietin (TPO), interleukin-3 (IL-3), and/or interleukin-6 (IL-6).

", "id": "sg:patent.US-20090275131-A1", "keywords": [ "mast cell", "method", "pluripotent stem cell", "vitro", "pluripotent cell", "induced pluripotent stem cell", "human embryonic stem cell", "cell", "drug development", "growth factor", "culture medium", "invention", "stem cell factor", "TPO", "Interleukin-3", "Interleukin-6" ], "name": "METHOD FOR PRODUCTION OF MAST CELLS FROM STEM CELLS", "sameAs": [ "https://app.dimensions.ai/details/patent/US-20090275131-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:34", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_83943d3a.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-20090275131-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-20090275131-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-20090275131-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-20090275131-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

70 TRIPLES      13 PREDICATES      38 URIs      23 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-20090275131-A1 schema:about anzsrc-for:2581
2 anzsrc-for:2995
3 schema:author Ncc9ea57dc03b45708f484395d89afa6c
4 schema:citation sg:pub.10.1038/nbt1177
5 https://doi.org/10.1002/jez.535
6 https://doi.org/10.1016/0022-1759(95)00034-8
7 https://doi.org/10.1016/j.exphem.2008.04.003
8 https://doi.org/10.1016/j.theriogenology.2009.09.032
9 https://doi.org/10.1016/j.theriogenology.2009.11.020
10 https://doi.org/10.1016/j.theriogenology.2010.04.020
11 https://doi.org/10.1038/news.2008.1336
12 https://doi.org/10.1634/stemcells.2007-0348
13 schema:description <p id="p-0001" num="0000">Provided are methods for generating mast cells from pluripotent stem cells in vitro. Methods are disclosed for the differentiation of pluripotent cells, such as iPS cells and/or human embryonic stem cells, into mast cells. The resulting mast cells may be used for various purposes including screening cells for drug development and research. Growth factors which may be included in culture media according to the present invention include stem cell factor (SCF), FLT-3 ligand, thrombopoietin (TPO), interleukin-3 (IL-3), and/or interleukin-6 (IL-6).</p>
14 schema:keywords Interleukin-3
15 Interleukin-6
16 TPO
17 cell
18 culture medium
19 drug development
20 growth factor
21 human embryonic stem cell
22 induced pluripotent stem cell
23 invention
24 mast cell
25 method
26 pluripotent cell
27 pluripotent stem cell
28 stem cell factor
29 vitro
30 schema:name METHOD FOR PRODUCTION OF MAST CELLS FROM STEM CELLS
31 schema:sameAs https://app.dimensions.ai/details/patent/US-20090275131-A1
32 schema:sdDatePublished 2019-03-07T15:34
33 schema:sdLicense https://scigraph.springernature.com/explorer/license/
34 schema:sdPublisher N467072aacaa94f3fb0118adf65a60c86
35 sgo:license sg:explorer/license/
36 sgo:sdDataset patents
37 rdf:type sgo:Patent
38 N37550dd9e5ff4007b6db7b15f3444a1c schema:name Christine Daigh
39 rdf:type schema:Person
40 N467072aacaa94f3fb0118adf65a60c86 schema:name Springer Nature - SN SciGraph project
41 rdf:type schema:Organization
42 Ncc9ea57dc03b45708f484395d89afa6c rdf:first N37550dd9e5ff4007b6db7b15f3444a1c
43 rdf:rest Nfc61d22848c4450d86640f83ce3857bc
44 Ne814fddee9d14a6fb1c5bf3efebfdd67 schema:name Deepika Rajesh
45 rdf:type schema:Person
46 Nfc61d22848c4450d86640f83ce3857bc rdf:first Ne814fddee9d14a6fb1c5bf3efebfdd67
47 rdf:rest rdf:nil
48 anzsrc-for:2581 schema:inDefinedTermSet anzsrc-for:
49 rdf:type schema:DefinedTerm
50 anzsrc-for:2995 schema:inDefinedTermSet anzsrc-for:
51 rdf:type schema:DefinedTerm
52 sg:pub.10.1038/nbt1177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030407065
53 https://doi.org/10.1038/nbt1177
54 rdf:type schema:CreativeWork
55 https://doi.org/10.1002/jez.535 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049055947
56 rdf:type schema:CreativeWork
57 https://doi.org/10.1016/0022-1759(95)00034-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033328601
58 rdf:type schema:CreativeWork
59 https://doi.org/10.1016/j.exphem.2008.04.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035969756
60 rdf:type schema:CreativeWork
61 https://doi.org/10.1016/j.theriogenology.2009.09.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027967774
62 rdf:type schema:CreativeWork
63 https://doi.org/10.1016/j.theriogenology.2009.11.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013693696
64 rdf:type schema:CreativeWork
65 https://doi.org/10.1016/j.theriogenology.2010.04.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007552463
66 rdf:type schema:CreativeWork
67 https://doi.org/10.1038/news.2008.1336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056454267
68 rdf:type schema:CreativeWork
69 https://doi.org/10.1634/stemcells.2007-0348 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011839783
70 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...